Leading drug-makers Pfizer and BioNTech submitted a request to get the approval of the Food and Dug Authority (FDA) for booster shot for children between 5 and 11.
The request of the drug-makers came after a new study showed that the booster shots could give the children strong immune response against the COVID-19.
The booster dose will be given to children six months after receiving the essential doses.
It is worthy to mention that the US health authorities approved a second COVID-19 booster dose for two vaccines: Pfizer and Moderna, for people aged 50 and older last March.
The essential motive for issuing such a decision was raising the immune response of aged people against the Omicron variant risks.
The U.S. Food and Drug Administration agency said the fourth dose will be dedicated to those who were vaccinated by the Pfizer Inc (PFE.N)/BioNTech and Moderna vaccines are to be administered at least four months after the latest dose.
The FDA also authorized the fourth shot for younger people who aged 12 and older for the Pfizer/BioNTech shot and 18 and older for Moderna’s.
Follow the latest news on Google News
